Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial
Crossref DOI link: https://doi.org/10.1007/s10096-016-2819-1
Published Online: 2016-10-28
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bao, H.
Lv, Y.
Wang, D.
Xue, J.
Yan, Z.
Funding for this research was provided by:
National Science and Technology Major Project, China (2013ZX09303001)
License valid from 2016-10-28